Role of carvedilol in atrial fibrillation: insights from clinical trials
- 6 May 2004
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 93 (9), 53-57
- https://doi.org/10.1016/j.amjcard.2004.01.023
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?Journal of the American College of Cardiology, 2003
- β-Blockers are effective in congestive heart failure patients with atrial fibrillationJournal of Cardiac Failure, 2003
- DigoxinProgress in Cardiovascular Diseases, 2002
- HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approachesJournal of Cardiac Failure, 1999
- Dofetilide in Patients with Congestive Heart Failure and Left Ventricular DysfunctionNew England Journal of Medicine, 1999
- Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimensJournal of the American College of Cardiology, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- AUGMENTED DIGOXIN CONCENTRATIONS WITH CARVEDILOL DOSING IN MILD-MODERATE HEART FAILUREClinical Journal of Sport Medicine, 1994
- Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- Optimal heart rate control for patients with chronic atrial fibrillation: Are pharmacologic choices truly changing?American Heart Journal, 1992